Found: 75
Select item for more details and to access through your institution.
A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 5, p. 490, doi. 10.1016/j.clpt.2004.07.016
- By:
- Publication type:
- Article
Etoposide combined with interferon alfa-2b: Novel exploitation of established etoposide pharmacokinetics and pharmacodynamics<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 3, p. 349, doi. 10.1016/S0009-9236(96)80013-0
- By:
- Publication type:
- Article
Modulation of vinblastine resistance with cyclosporine: A phase I study.
- Published in:
- Clinical Pharmacology & Therapeutics, 1993, v. 54, n. 4, p. 421, doi. 10.1038/clpt.1993.169
- By:
- Publication type:
- Article
The Targeted Agent and Profiling Utilization Registry Study: A pragmatic clinical trial.
- Published in:
- Clinical Trials, 2023, v. 20, n. 6, p. 699, doi. 10.1177/17407745231182013
- By:
- Publication type:
- Article
Access versus evidence: The regulators’ dilemma.
- Published in:
- Clinical Trials, 2018, v. 15, n. 3, p. 240, doi. 10.1177/1740774518770660
- By:
- Publication type:
- Article
Biological, clinical, and psychosocial correlates at the interface of cancer and aging research.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Biological, Clinical, and Psychosocial Correlates at the Interface of Cancer and Aging Research.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 8, p. 581
- By:
- Publication type:
- Article
Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 22, p. 1698, doi. 10.1093/jnci/djq390
- By:
- Publication type:
- Article
Measuring Disease-Free Survival and Cancer Relapse Using Medicare Claims From CALGB Breast Cancer Trial Participants (Companion to 9344).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 18, p. 1335, doi. 10.1093/jnci/djj363
- By:
- Publication type:
- Article
Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Oncology Physician and Nurse Practices and Attitudes Regarding Offering Clinical Trial Results To Study Participants.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 8, p. 629, doi. 10.1093/jnci/djh096
- By:
- Publication type:
- Article
Silence is golden: gene hypermethylation and survival in large-cell lymphoma.
- Published in:
- 2002
- By:
- Publication type:
- commentary
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231156382
- By:
- Publication type:
- Article
Paradoxical relationship between acetylator phenotype and amonafide toxicity.
- Published in:
- Clinical Pharmacology & Therapeutics, 1991, v. 50, n. 5, p. 573, doi. 10.1038/clpt.1991.183
- By:
- Publication type:
- Article
Adaptive control of etoposide administration: Impact of interpatient pharmacodynamic variability.
- Published in:
- Clinical Pharmacology & Therapeutics, 1989, v. 45, n. 3, p. 226, doi. 10.1038/clpt.1989.22
- By:
- Publication type:
- Article
Estimation of the effect of food on the disposition of oral 5-fluorouracil in combination with eniluracil.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Talking the Talk About Tumor Genomic Testing.
- Published in:
- 2020
- By:
- Publication type:
- editorial
Hans Christian Andersen and the Value of New Cancer Treatments.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Response.
- Published in:
- 2016
- By:
- Publication type:
- commentary
Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Leveraging Biospecimen Resources for Discovery or Validation of Markers for Early Cancer Detection.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 4, p. 1, doi. 10.1093/jnci/djv012
- By:
- Publication type:
- Article
Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Generalizability of Trial Results to Elderly Medicare Patients With Advanced Solid Tumors (Alliance 70802).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 107, n. 1, p. 1, doi. 10.1093/jnci/dju336
- By:
- Publication type:
- Article
Highlights from the 2015 WIN Symposium: novel targets, innovative agents, and advanced technologies--a WINning strategy?
- Published in:
- 2015
- By:
- Publication type:
- Proceeding
Highlights from the 2013 WIN Symposium: personalised cancer therapy from innovation to implementation.
- Published in:
- Ecancermedicalscience, 2013, v. 7, n. 334-360, p. 1, doi. 10.3332/ecancer.2013.344
- By:
- Publication type:
- Article
'Strategic' development of precision cancer medicine in the United States.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 7, p. 1747, doi. 10.1002/1878-0261.13023
- By:
- Publication type:
- Article
Personalized cancer medicine – A strategy to counteract an increasing cancer challenge
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Hydroxyurea and Etoposide: In Vitro Synergy and Phase I Clinical Trial2.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 17, p. 1412, doi. 10.1093/jnci/80.17.1412
- By:
- Publication type:
- Article
Effect of Mopidamol on Survival in Carcinoma of the Lung and Colon: Final Report of Veterans Administration Cooperative Study No. 188.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 2, p. 90
- By:
- Publication type:
- Article
Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e405, doi. 10.1634/theoncologist.2019-0698
- By:
- Publication type:
- Article
Improving Cancer Diagnosis and Care: Patient Access to High‐Quality Oncologic Pathology.
- Published in:
- Oncologist, 2019, v. 24, n. 10, p. 1287, doi. 10.1634/theoncologist.2019-0261
- By:
- Publication type:
- Article
Publicly Funded Clinical Trials and the Future of Cancer Care.
- Published in:
- Oncologist, 2013, v. 18, n. 2, p. 232, doi. 10.1634/theoncologist.2012-0423
- By:
- Publication type:
- Article
Abstract 1 -- Publicly Funded Clinical Trials and the Future of Cancer Care.
- Published in:
- 2012
- By:
- Publication type:
- Abstract
A Cancer and Leukemia Group B Phase II Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma (CALGB 80603)
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
A Cancer and Leukemia Group B Phase II Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma (CALGB 80603).
- Published in:
- Oncologist, 2010, v. 15, n. 12, p. 1310, doi. 10.1634/theoncologist.2010-0152
- By:
- Publication type:
- Article
Commentary: Tackling the Challenges of Developing Targeted Therapies for Cancer.
- Published in:
- Oncologist, 2010, v. 15, n. 5, p. 484, doi. 10.1634/theoncologist.2010-0079
- By:
- Publication type:
- Article
Data Submission Standards and Evidence Requirements.
- Published in:
- Oncologist, 2010, v. 15, n. 5, p. 488, doi. 10.1634/theoncologist.2009-0260
- By:
- Publication type:
- Article
The National Clinical Trials Network and the cooperative groups: The road not taken.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 23, p. 5008, doi. 10.1002/cncr.33210
- By:
- Publication type:
- Article
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2018, v. 142, n. 10, p. 1242, doi. 10.5858/arpa.2018-0901-SA
- By:
- Publication type:
- Article
Breaking a Vicious Cycle.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 196, p. 1, doi. 10.1126/scitranslmed.3005950
- By:
- Publication type:
- Article
Accrual to Cancer Clinical Trials in the Era of Molecular Medicine.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 75, p. 1, doi. 10.1126/scitranslmed.3001712
- By:
- Publication type:
- Article
Gonadal dysfunction in patients receiving chemotherapy for cancer.
- Published in:
- 1980
- By:
- Publication type:
- journal article
Hypomagnesemia and Renal Magnesium Wasting in Patients Receiving Cisplatin.
- Published in:
- 1979
- By:
- Publication type:
- Case Study
Patient advocates' role in clinical trials.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 19, p. 4801, doi. 10.1002/cncr.27485
- By:
- Publication type:
- Article
Development and Validation of a Natural Language Processing Tool to Generate the CONSORT Reporting Checklist for Randomized Clinical Trials.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 10, p. e2014661, doi. 10.1001/jamanetworkopen.2020.14661
- By:
- Publication type:
- Article
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 14, p. 2790, doi. 10.1002/cam4.4635
- By:
- Publication type:
- Article
Olaparib Extends Survival by >1 Year in Women with Relapsed Ovarian Cancer and BRCA Mutation.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2020, v. 11, n. 10, p. 376
- By:
- Publication type:
- Article
Adjuvant Osimertinib a "Home Run" in Patients with Localized NSCLC.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2020, v. 11, n. 10, p. 359
- By:
- Publication type:
- Article